Go Deep
Solasia Pharma K.K.
Solasia Pharma K.K. Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 17,809 | -8.5 | 5.26 | 0.05 | 16.95 |
Solasia Pharma K.K. Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 2,000,000.0 | 6,000,000.0 | 338,000,000.0 | 42,000,000.0 |
| Net Profit | -272,000,000.0 | -307,000,000.0 | -150,000,000.0 | -171,000,000.0 |
| EPS | — | -1.1 | — | — |
Solasia Pharma K.K. Revenue & Profit: Last 5 Years
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Revenue | 429,000,000.0 | 316,000,000.0 | 617,000,000.0 | 1,092,000,000.0 | — |
| Net Profit | -876,000,000.0 | -1,941,000,000.0 | -1,112,000,000.0 | -2,548,000,000.0 | — |
| EPS | -3.3 | -8.9 | -6.6 | -16.8 | — |
Solasia Pharma K.K. Balance Sheet
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Total Assets | 2,078,000,000.0 | 1,356,000,000.0 | 2,229,000,000.0 | 3,134,000,000.0 | — |
| Total Liabilities | 458,000,000.0 | 321,000,000.0 | 354,000,000.0 | 472,000,000.0 | — |
| Total Equity | 1,620,000,000.0 | 1,035,000,000.0 | 1,874,000,000.0 | 2,662,000,000.0 | — |
Owes vs Owns
Solasia Pharma K.K. owed ¥0.23 for every ¥1 it owned in Jun 2026, up from ¥0.15 in Dec 2022.
| Period | Jun 2026 | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|---|
| Owes vs Owns | 0.23× | 0.22× | 0.24× | 0.16× | 0.15× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
Solasia Pharma K.K. Assets & Liabilities Breakdown (JPY millions)
What it owns — Dec 2025
Cash & short-term investments 66.3%Receivables 16.4%Inventory 5.4%Fixed assets (tangible) 2.8%Long-term investments 2.1%Other assets 6.9%
How it's funded — Dec 2025
Long-term debt 0.8%Payables 19.4%Other liabilities 1.9%Shareholders' equity 78.0%
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 1,378.0 | 875.0 | 728.0 | 803.0 |
| Receivables | 341.0 | 203.0 | 67.0 | 572.0 |
| Inventory | 112.0 | 127.0 | 122.0 | 14.0 |
| Fixed assets (tangible) | 59.0 | 61.0 | 81.0 | 63.0 |
| Intangible assets | 0.0 | 0.0 | 1,117.0 | 1,570.0 |
| Long-term investments | 44.0 | 44.0 | 6.0 | 11.0 |
| Other assets | 144.0 | 46.0 | 108.0 | 101.0 |
| Liabilities & equity | ||||
| Short-term debt | 0.0 | 25.0 | 33.0 | 37.0 |
| Long-term debt | 16.0 | 12.0 | 27.0 | 0.0 |
| Payables | 403.0 | 258.0 | 213.0 | 332.0 |
| Other liabilities | 39.0 | 26.0 | 81.0 | 103.0 |
| Shareholders' equity | 1,620.0 | 1,035.0 | 1,875.0 | 2,662.0 |
| Net tangible assets | 1,620.0 | 1,035.0 | 757.0 | 1,092.0 |
Solasia Pharma K.K. Cash Flow
| Line Item | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|
| Operating Activities | -1,033,000,000.0 | -359,000,000.0 | -2,074,000,000.0 | -2,473,000,000.0 |
| Investing Activities | 0.0 | 0.0 | -418,000,000.0 | -164,000,000.0 |
| Financing Activities | 1,180,000,000.0 | 275,000,000.0 | 2,571,000,000.0 | 361,000,000.0 |